account4:29pm EDT * FDA staff: Pfizer cancer drug showed uncertain benefits * Staff also question Novartis cancer drug data * FDA panel set to review both drugs on Tuesday * Pfizer shares up 0.6 pct...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 3-Pfizer, Novartis question pancreatic cancer drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account